From insilico meddicine — the beginning of an AI healthcare revolution.
Poly Mamoshina on Machine Learning for small molecule drug discovery and the beginning of an AI healthcare revolution — interviewed at the Undoing Aging conference in Berlin 2019!
Polina Mamoshina is a senior research scientist at Insilico Medicine, Inc (www.insilico.com), a Baltimore-based bioinformatics and deep learning company focused on reinventing drug discovery and biomarker development and a part of the computational biology team of Oxford University Computer Science Department. Polina graduated from the Department of Genetics of the Moscow State University. She was one of the winners of GeneHack a Russian nationwide 48-hour hackathon on bioinformatics at the Moscow Institute of Physics and Technology attended by hundreds of young bioinformaticians. Polina is involved in multiple deep learning projects at the Pharmaceutical Artificial Intelligence division of Insilico Medicine working on the drug discovery engine and developing biochemistry, transcriptome, and cell-free nucleic acid-based biomarkers of aging and disease. She recently co-authored seven academic papers in peer-reviewed journals.
https://scholar.google.com/citations?user=YrLgl8gAAAAJ&hl=en
https://uk.linkedin.com/in/polymamoshina
https://cogx.co/speakers/polina-mamoshina/
Many thanks for watching!
Consider supporting SciFuture by:
a) Subscribing to the SciFuture YouTube channel: http://youtube.com/subscription_center?add_user=TheRationalFuture
b) Donating
- Bitcoin: 1BxusYmpynJsH4i8681aBuw9ZTxbKoUi22
- Etherium: 0xd46a6e88c4fe179d04464caf42626d0c9cab1c6b
- Patreon: https://www.patreon.com/scifuture
c) Sharing the media SciFuture creates: http://scifuture.org
Kind regards.
Adam Ford
- Science, Technology & the Future.
Comments are closed.